GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Research & Development

PharmaTher Holdings (XCNQ:PHRM) Research & Development : C$2.80 Mil (TTM As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. PharmaTher Holdings's Research & Development for the three months ended in Feb. 2024 was C$0.20 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 was C$2.80 Mil.

PharmaTher Holdings Research & Development Historical Data

The historical data trend for PharmaTher Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Research & Development Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Research & Development
0.75 2.61 3.02

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.85 1.07 0.68 0.20

PharmaTher Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings  (XCNQ:PHRM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PharmaTher Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings (XCNQ:PHRM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Research & Development
Comparable Companies
XCNQ:COOL XCNQ:MDMA XCNQ:ASEP TSXV:QPT XCNQ:TELI NEOE:BMND TSX:AEZS TSXV:NRX XCNQ:BLAB TSXV:KNE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
PHRRF:USA
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Website
https://www.pharmather.com
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines